Lamotrigina Doc

Lamotrigine, the active ingredient in Lamotrigina Doc, is an anticonvulsant presented as a tablet for oral use. It works by inhibiting voltage‑gated sodium channels, thereby stabilizing neuronal membranes and reducing excessive glutamate release. Clinically, it is used to control seizures in epilepsy and to prevent mood swings in bipolar disorder.

GNH USA supplies Lamotrigina Doc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality compliance with EU standards and reliable global distribution. The product meets stringent manufacturing guidelines and is available for bulk procurement.

Lamotrigine is indicated for conditions involving abnormal neuronal excitability, primarily within the seizure and mood disorder spectrum, and is used as monotherapy or adjunctive therapy.

- Epilepsy: Reduces frequency and severity of focal and generalized seizures in patients of various ages. - Bipolar disorder: Helps maintain mood stability by decreasing the occurrence of depressive and manic episodes. - Adjunctive therapy for refractory seizures: Used in combination with other antiepileptic drugs to improve seizure control when monotherapy is insufficient.

Lamotrigine may cause a range of adverse reactions, from mild to severe. Patients should be aware of both common and rare side effects.

Common Side Effects: - Dizziness - Headache - Nausea - Rash (mild) - Blurred vision - Fatigue

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., bullous dermatitis) - Blood dyscrasias such as agranulocytosis - Hepatic failure or severe hypersensitivity reactions

When prescribing lamotrigine, clinicians should consider several safety measures to minimize risk.

- Dose titration: Adjust gradually to reduce the likelihood of rash. - Skin reactions: Monitor for any rash and discontinue immediately if severe. - Hepatic function: Use caution in patients with liver impairment. - Concomitant valproate: May increase lamotrigine levels; dose adjustments are required. - Pregnancy: Use only if the therapeutic benefit outweighs potential fetal risk. - Store at ambient temperature: Keep in the original container, protect from moisture and light.

Lamotrigine interacts with several medications that can alter its plasma concentration or increase adverse effects.

Major Interactions (Avoid): - Valproic acid: Inhibits metabolism, markedly increasing lamotrigine levels. - Carbamazepine: Induces metabolism, reducing lamotrigine exposure. - Oral contraceptives: May lower lamotrigine concentrations, reducing efficacy.

Moderate Interactions (Monitor Closely): - Phenytoin: Enzyme inducer that can decrease lamotrigine levels. - Phenobarbital: Similar inducing effect, may require dose adjustment. - Rifampin: Strong inducer, may lower lamotrigine concentrations.